Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

[1]  D. Paniagua,et al.  Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Storb,et al.  A proposed objective way to assess results of randomized prospective clinical trials with acute graft‐versus‐host disease as an outcome of interest , 2001, British journal of haematology.

[3]  M. Thornquist,et al.  Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome. , 2001 .

[4]  R Storb,et al.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.

[5]  M. Boeckh,et al.  Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. , 2000, Blood.

[6]  H. Deeg,et al.  Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Ponec,et al.  Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. , 1999, Gastrointestinal endoscopy.

[8]  R. Ponec,et al.  Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. , 1998, Transplantation.

[9]  Anajane G. Smith,et al.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.

[10]  H. Deeg,et al.  Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation , 1998, Bone Marrow Transplantation.

[11]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[12]  M. Levenstein,et al.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.

[13]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[14]  R. Clift.  Marrow transplantation for chronic myeloid leukemia. , 1995, Cancer treatment and research.

[15]  R. Lo,et al.  Etiology and outcome of diarrhea after marrow transplantation: a prospective study. , 1994, Gastroenterology.

[16]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. , 1994, Blood.

[17]  M. Boeckh,et al.  Strategies for the prevention of cytomegalovirus disease after marrow transplantation. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Schoch,et al.  Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.

[19]  U. Graeven,et al.  Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. , 1992, Blood.

[20]  H. Deeg,et al.  Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. , 1992, Blood.

[21]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. , 1991, Blood.

[22]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.

[23]  K. Sullivan,et al.  Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.

[24]  D. Snover,et al.  Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. , 1990, Blood.

[25]  H. Deeg,et al.  Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial , 1989, British journal of haematology.

[26]  H. Deeg,et al.  Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. , 1989, Blood.

[27]  J. Meyers,et al.  Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. , 1987, Scandinavian journal of infectious diseases.

[28]  R. Hackman,et al.  A PROSPECTIVE STUDY OF UNEXPLAINED NAUSEA AND VOMITING AFTER MARROW TRANSPLANTATION , 1986, Transplantation.

[29]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[30]  G. McDonald,et al.  Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients. , 1986, Human pathology.

[31]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[32]  Snover Dc.  Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis. , 1985 .

[33]  K. Sullivan,et al.  Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. , 1983, The New England journal of medicine.

[34]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.